Viracta Therapeutics
-
2016 November 01
Company Description
Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients.
iracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
-
Manufacturer:
Science and Engineering -
Formed:
November 1, 2016 -
Company Website:
-
Company E-mail:
-
Company Address:
4747 Executive Dr Suite 700San Diego, CAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits